跳至主要内容
临床试验/EUCTR2015-004377-33-NO
EUCTR2015-004377-33-NO进行中(未招募)不适用

Botulinum toxin type A Block for the sphenopalatine ganglion in chronic rhinosinusitis With nasal polyposis

Department of Neuroscience, NT0 个研究点开始时间: 2015年12月16日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Informed and written consent
  • 2. Chronic rhinosinusitis with nasal polyposis defined in EPOS criteria
  • 3. Person from 18 to 70 years old
  • 4. Failed prophylactic treatments with local nasal steroids
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 2

排除标准

  • 1. Heart or lung disease or any kind of systematic or local disease or illness that may significantly increase the risk of complications for the procedure related to injection
  • 2. Psychiatric illness that hinders participation in the study
  • 3. Known pregnancy or breast feeding
  • 4. Inadequate use of contraceptives
  • 5. Abuse of medications, narcotics or alcohol
  • 6. Anomalies which hinder or impede the used method of injection
  • 7. Allergy or any other hypersensitivity reactions against marcain, lidocaine, xylocain or adrenalin
  • 8. Allergy or any other hypersensitivity reactions against botulinum toxin type A, Botox or any of it's constituents or any other related medication
  • 9. Treatment with medication that can interact with botulinum toxin type A
  • 10. Suspicion of allergy to be one of the main causes of polyposis
  • 11. Suspicion of Samters triade

研究者

发起方
Department of Neuroscience, NT

相似试验

Botox injection in nerve bundle against nasal... | 临床试验